Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lasix nebulizer for acute viral bronchiolitis in hospitalized children
IRCT20250608066126N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of furosemide in bronchiolitis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Severity of bronchiolitis, Duration of hospitalization and 1 more. Started Jul 2025; status: completed.
02
Drugs
furosemide
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on IRCT20250608066126N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250608066126N1.